SANDOVAL DAVID I. (General Counsel) received a stock award from MAXCYTE, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/18/2025ACC: 0000905148-25-000963
Officer· General Counsel
Since Feb 2024
+115.63K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
115.63K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+23.13K
Price / share
—
Trade value
—
% of position
55.8%
3/14/2025
41.45K→64.57K
Total
Net shares
+23.13K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/14/2025 | A · Award | +23.13K | — | — | 55.8% | 41.45K | 64.57K |
| Total | +23.13K | $0.00 | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Common Stock
92.50K shares
Shares
+92.50K
Strike price
3.29
Held after
92.50K
Exercisable
—
3/14/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock92.50K shares | 3/14/2025 | A · Award | +92.50K | 3.29 | — | 92.50K |